SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity

Michael Strasser; Alexandra Feldman; M Schranz; Lars Stechemesser; L Denkmayr; S Ruhaltinger; G Strebinger; U Huber-Schonauer; D Niederseer; S Zandanell; Bernhard Paulweber; Elmar Aigner; C Datz

SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity

Michael Strasser
, Alexandra Feldman
, M Schranz
, Lars Stechemesser
, L Denkmayr
, S Ruhaltinger
, G Strebinger
, U Huber-Schonauer
, D Niederseer
, S Zandanell
, Bernhard Paulweber
, Elmar Aigner
, C Datz

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	S425-S426
Fachzeitschrift	JOURNAL OF HEPATOLOGY
Jahrgang	66
Ausgabenummer	1
Publikationsstatus	Veröffentlicht - 2017
Veranstaltung	International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver - Amsterdam, NETHERLANDS Dauer: 19 Apr. 2017 → 23 Apr. 2017

Dieses zitieren

Strasser, M., Feldman, A., Schranz, M., Stechemesser, L., Denkmayr, L., Ruhaltinger, S., Strebinger, G., Huber-Schonauer, U., Niederseer, D., Zandanell, S., Paulweber, B., Aigner, E., & Datz, C. (2017). SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity. JOURNAL OF HEPATOLOGY , 66(1), S425-S426.

Strasser, Michael ; Feldman, Alexandra ; Schranz, M et al. / SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity. in: JOURNAL OF HEPATOLOGY 2017 ; Jahrgang 66, Nr. 1. S. S425-S426.

@article{c5461ddd9eec4d97962cccc9be87a607,

title = "SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity",

author = "Michael Strasser and Alexandra Feldman and M Schranz and Lars Stechemesser and L Denkmayr and S Ruhaltinger and G Strebinger and U Huber-Schonauer and D Niederseer and S Zandanell and Bernhard Paulweber and Elmar Aigner and C Datz",

year = "2017",

language = "English",

volume = "66",

pages = "S425--S426",

journal = "JOURNAL OF HEPATOLOGY ",

issn = "0168-8278",

publisher = "Elsevier ",

number = "1",

note = "International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver ; Conference date: 19-04-2017 Through 23-04-2017",

}

Strasser, M , Feldman, A, Schranz, M, Stechemesser, L, Denkmayr, L, Ruhaltinger, S, Strebinger, G, Huber-Schonauer, U, Niederseer, D, Zandanell, S, Paulweber, B, Aigner, E & Datz, C 2017, 'SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity', JOURNAL OF HEPATOLOGY , Jg. 66, Nr. 1, S. S425-S426.

SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity. / Strasser, Michael ; Feldman, Alexandra; Schranz, M et al.
in: JOURNAL OF HEPATOLOGY , Jahrgang 66, Nr. 1, 2017, S. S425-S426.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity

AU - Strasser, Michael

AU - Feldman, Alexandra

AU - Schranz, M

AU - Stechemesser, Lars

AU - Denkmayr, L

AU - Ruhaltinger, S

AU - Strebinger, G

AU - Huber-Schonauer, U

AU - Niederseer, D

AU - Zandanell, S

AU - Paulweber, Bernhard

AU - Aigner, Elmar

AU - Datz, C

PY - 2017

Y1 - 2017

M3 - Abstract (Journal)

SN - 0168-8278

VL - 66

SP - S425-S426

JO - JOURNAL OF HEPATOLOGY

JF - JOURNAL OF HEPATOLOGY

IS - 1

T2 - International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver

Y2 - 19 April 2017 through 23 April 2017

ER -

Strasser M , Feldman A, Schranz M, Stechemesser L, Denkmayr L, Ruhaltinger S et al. SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidity. JOURNAL OF HEPATOLOGY . 2017;66(1):S425-S426.